Teleflex Takes Aim At Critical Care Market With Arrow Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Arrow International's R&D capabilities and complementary business model enticed Teleflex to buy the critical care device maker for $2 billion as part of an ongoing transformation of its device business, the firms said July 23 (see chart: "1Teleflex-Arrow Deal Basics")